Oleh Khilinskyi/iStock via Getty Images
Biogen upgraded at JPMorgan with $300 PT on 2027 pipeline catalysts, shares rise (BIIB:NASDAQ)
Veronique D
- Biogen (BIIB) shares rose 2.1% in Monday’s premarket trading after JPMorgan upgraded the stock to overweight from neutral, citing an increasingly attractive pipeline of catalysts expected in 2027.
- The brokerage set a PT of $300, which implies a 33% increase from last close.